CIMG Inc. IPO - What You Need to Know

Thinking about jumping into the CIMG Inc. IPO? It is exciting to get in on the ground floor, but let’s look at what is happening behind the scenes before you invest.

1. What does this company actually do?

CIMG Inc. operates in Hong Kong, mainland China, Singapore, and Florida. They focus on three areas: "Maca" root supplements, food and medicine, and computing power equipment. They operate through 13 different subsidiaries. This complex structure makes it hard to track how the business works or where the money goes. Financially, the company is struggling. For the fiscal year ending December 31, 2025, they reported a loss of approximately $12.4 million. Their core business cannot currently cover their costs.

2. The Big News: A Risky Offering

CIMG plans to sell up to 900 million "units." Each unit includes one share of stock and one warrant, which lets you buy another share later at a set price.

The catch? They are pricing these units at $0.015 each and accepting Bitcoin as payment. They aim to raise $13.5 million now, but they plan to raise up to $650 million total. To do this, they will eventually issue billions of new shares. This means more shares issued, reducing your ownership percentage, so your slice of the pie gets smaller. This massive potential increase in shares is meant to fund daily operations, but it creates a heavy weight on the stock price.

3. Why are they using Bitcoin?

The company claims they want Bitcoin as a "treasury reserve," or a digital piggy bank. They admit this has nothing to do with their actual product sales. If you pay in Bitcoin, they value your payment based on a seven-day average price of $65,000 per Bitcoin. By holding Bitcoin, the company exposes its balance sheet to extreme price swings. The value of their "reserve" could change wildly, regardless of how well their Maca or computing businesses perform.

4. The Nasdaq Drama: They’ve Been Kicked Off

This is a major red flag. CIMG previously traded on the Nasdaq. They were suspended in March 2026 and delisted in May 2026 for failing to meet rules regarding financial reporting and share prices. They now trade on the "over-the-counter" (OTC) market. This is a less regulated, "wild west" environment where it is often harder to buy or sell shares quickly. There is no guarantee they will return to a major exchange. The lack of liquidity on the OTC market may make it difficult for you to sell your shares when you want.

5. What are the main risks?

• "Going Concern" Warning: Their own auditors have "substantial doubt" about the company’s ability to stay in business. They are losing money and may run out of cash.
• The Dilution Trap: Because they want to raise hundreds of millions by selling billions of units, your percentage of ownership could shrink rapidly.
• Regulatory & Audit Risks: With operations in China and other regions, they face unpredictable government rules. If they cannot provide U.S. regulators with access to their books, they could be banned from U.S. markets.
• Management Complexity: Management is spread across many subsidiaries. They admit that running the business is expensive and difficult. This structure increases the risk of inefficiency and mistakes in financial reporting.

Disclaimer: I am an AI, not a financial advisor. This situation involves extreme risks, including the potential for total loss of your investment. The company has been delisted from the Nasdaq, is struggling to stay afloat, and has a plan to issue billions of shares that could wipe out your value. Before you make any decisions, please take the time to read the official "Prospectus" filed with the SEC—it contains the fine print that every investor needs to see.